Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04592562 · ClinicalTrials.gov registry record · NA
Genicular Artery Embolization to Reduce Pain Associated With Unilateral Mild to Moderate Osteoarthritis
A NA study, sponsored by University of Chicago.
- Completed
- Registry status
- NA
- Development phase
- 5
- Enrollment target
NCT04592562: Completed NA study, sponsored by University of Chicago.
NCT04592562 is a NA study that has completed, run by University of Chicago. The registered enrollment target is 5 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04592562, a NA study, has completed, sponsored by University of Chicago.
- COMPLETED
- Registry status
- NA
- Development phase
- 5 participants
- Enrollment target
Study Summary
The goal of this study is to perform a feasibility study to show the effectiveness of the genicular artery embolization procedure in reducing bilateral or unilateral osteoarthritic knee pain at 12 months as measured by WOMAC (Western Ontario and McMaster Universities Osteoarthritis Index) score, Knee Injury and Osteoarthritis Outcome (KOOS) score, and Oswestry Disability Index.
Primary Outcome
The reduction of Bilateral or unilateral knee pain and dysfunction associated with mild to moderate osteoarthritis at 12 months as measured by WOMAC (Western Ontario and McMaster Universities Osteoarthritis Index) score
Interventions
- DEVICE the Terumo Hydropearl® microspheres device
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2021-09-22 |
| Est. Completion | 2024-05-28 |
| Phase | NA |
What the finished NCT04592562 record still lists
NCT04592562 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which the Terumo Hydropearl® microspheres device is the first listed.
NCT04592562 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04592562 about?
NCT04592562 is a clinical study titled "Genicular Artery Embolization to Reduce Pain Associated With Unilateral Mild to Moderate Osteoarthritis". The goal of this study is to perform a feasibility study to show the effectiveness of the genicular artery embolization procedure in reducing bilateral or unilateral osteoarthritic knee pain at 12 months as measured by WOMAC (Western Ontario and McMaster Universities Osteoarthritis Index) score, Kne...
What is the current status of trial NCT04592562?
This trial is currently completed. It is a NA study. The enrollment target is 5 participants. The study started on 2021-09-22. Estimated completion is 2024-05-28.
What interventions are being tested in trial NCT04592562?
The interventions under investigation include: the Terumo Hydropearl® microspheres device (DEVICE).
Who is sponsoring clinical trial NCT04592562?
This trial is sponsored by University of Chicago, which has 796 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04592562's enrollment target sits among peer trials
5 1988th of 2000 higher than 5 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI